Orna Therapeutics and AvenCell Therapeutics join 500 Forge! The newly redeveloped 500 Forge at Arsenal Yards’ life science campus officially welcomed two companies – Orna Therapeutics and AvenCell Therapeutics.
Orna Therapeutics – A Cambridge-based biotechnology company is creating a fully engineered oRNATM circular RNAs, which is a completely new class of RNA medicines that will change the way we treat disease. With the power of superior delivery techniques, Orna is pioneering the next breakthrough in RNA therapeutics.
AvenCell Therapeutics – Developing next generation immunotherapies for hard-to-treat cancers.
Welcome to 500 Forge and Arsenal Yards!